Status
Conditions
Treatments
About
This is a multi-center, randomized controlled trial of 284 subjects (142 in each group). Patients will be blinded to the fixation method used. The objective of this study is to compare the efficacy and safety of the LiquiBand FIX8® device to the tack-based control device (AbsorbaTack™) for laparoscopic groin hernia (inguinal or femoral) repair. The primary outcome measure is an improvement in pain score measured by VAS at 6 months. Secondary outcomes include the ability to affix hernia mesh, the ability to approximate the peritoneum, recurrence rate, and quality of life (Carolina Comfort Scale).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Is male or female, ≥22 years of age
Is willing and able to give written informed consent
Has a primary or recurrent groin hernia (unilateral or bilateral, inguinal or femoral)
Is currently scheduled and eligible for TAPP or TEP laparoscopic groin hernia repair (inguinal or femoral)
Hernia mesh to be used at the time of surgery is at least 4" x 6" in size and is one of the following;
Is willing and able to comply with the protocol assessments at time of surgery and during the post surgical follow up period
Exclusion criteria
Has a hernia type not suitable for laparoscopic hernia repair as determined by the Investigator (i.e. strangulated)
Subject has a recurrent groin hernia previously repaired laparoscopically, has an anatomical defect or had prior surgical procedures that in the opinion of the Investigator prevents access to the pre-peritoneal space for TAPP or TEP laparoscopic hernia repair
Is pregnant or actively breastfeeding
Has a known sensitivity to cyanoacrylate or formaldehyde,D&C Violet No.2 dye or any component of LiquiBand FIX8® or control device
Has an active or potential infection at the surgical site or systemic sepsis
Hernia mesh to be used at surgery is less than 4"x6" in size, or not one of the types of mesh listed in Inclusion Criteria above
Cannot tolerate general anaesthesia
Has any significant or unstable medical or psychiatric condition that, in the opinion of the Investigator, would interfere with his/her ability to participate in the study
Primary purpose
Allocation
Interventional model
Masking
284 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal